3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sezary Syndrome
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Thyroid Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lymphoma
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma
1
Bronchiolitis Obliterans Syndrome
1
Breast Neoplasms
1
Interventions
Cisplatin
76
Cetuximab
60
pembrolizumab
56
Radiotherapy, Intensity-Modulated
37
Radiotherapy
33
Carboplatin
31
Docetaxel
30
Fluorouracil
27
Nivolumab
26
Paclitaxel
20
Platinum
10
Albumin-Bound Paclitaxel
9
Surgical Procedures, Operative
8
Radiosurgery
8
Radiation
8
Erlotinib Hydrochloride
8
durvalumab
7
Bevacizumab
7
1,2-diaminocyclohexaneplatinum II citrate
7
epacadostat
6
Biopsy
6
Radiotherapy, Conformal
5
Ipilimumab
5
Immunoglobulin G
5
Gemcitabine
5
Capecitabine
5
130-nm albumin-bound paclitaxel
5
utomilumab
4
tremelimumab
4
palbociclib
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Squamous Cell Carcinoma of Head and Neck
×
Interleukin-15
×
Clear all
No trials found.